These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
421 related items for PubMed ID: 18194983
1. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity. Gecse K, Róka R, Ferrier L, Leveque M, Eutamene H, Cartier C, Ait-Belgnaoui A, Rosztóczy A, Izbéki F, Fioramonti J, Wittmann T, Bueno L. Gut; 2008 May; 57(5):591-9. PubMed ID: 18194983 [Abstract] [Full Text] [Related]
2. Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice. Annaházi A, Gecse K, Dabek M, Ait-Belgnaoui A, Rosztóczy A, Róka R, Molnár T, Theodorou V, Wittmann T, Bueno L, Eutamene H. Pain; 2009 Jul; 144(1-2):209-17. PubMed ID: 19450926 [Abstract] [Full Text] [Related]
3. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome. Róka R, Rosztóczy A, Leveque M, Izbéki F, Nagy F, Molnár T, Lonovics J, Garcia-Villar R, Fioramonti J, Wittmann T, Bueno L. Clin Gastroenterol Hepatol; 2007 May; 5(5):550-5. PubMed ID: 17336590 [Abstract] [Full Text] [Related]
4. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Piche T, Barbara G, Aubert P, Bruley des Varannes S, Dainese R, Nano JL, Cremon C, Stanghellini V, De Giorgio R, Galmiche JP, Neunlist M. Gut; 2009 Feb; 58(2):196-201. PubMed ID: 18824556 [Abstract] [Full Text] [Related]
5. Protease activated receptor 2: a new target for IBS treatment. Bueno L. Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():95-102. PubMed ID: 18924448 [Abstract] [Full Text] [Related]
6. Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS. Annaházi A, Ferrier L, Bézirard V, Lévêque M, Eutamène H, Ait-Belgnaoui A, Coëffier M, Ducrotté P, Róka R, Inczefi O, Gecse K, Rosztóczy A, Molnár T, Ringel-Kulka T, Ringel Y, Piche T, Theodorou V, Wittmann T, Bueno L. Am J Gastroenterol; 2013 Aug; 108(8):1322-31. PubMed ID: 23711626 [Abstract] [Full Text] [Related]
7. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Buhner S, Li Q, Vignali S, Barbara G, De Giorgio R, Stanghellini V, Cremon C, Zeller F, Langer R, Daniel H, Michel K, Schemann M. Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012 [Abstract] [Full Text] [Related]
8. Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients. Kerckhoffs AP, Ter Linde JJ, Akkermans LM, Samsom M. Neurogastroenterol Motil; 2008 Aug; 20(8):900-7. PubMed ID: 18363639 [Abstract] [Full Text] [Related]
9. Leaky gut in patients with diarrhea-predominant irritable bowel syndrome and inactive ulcerative colitis. Gecse K, Róka R, Séra T, Rosztóczy A, Annaházi A, Izbéki F, Nagy F, Molnár T, Szepes Z, Pávics L, Bueno L, Wittmann T. Digestion; 2012 Aug; 85(1):40-6. PubMed ID: 22179430 [Abstract] [Full Text] [Related]
10. PAR2 activation alters colonic paracellular permeability in mice via IFN-gamma-dependent and -independent pathways. Cenac N, Chin AC, Garcia-Villar R, Salvador-Cartier C, Ferrier L, Vergnolle N, Buret AG, Fioramonti J, Bueno L. J Physiol; 2004 Aug 01; 558(Pt 3):913-25. PubMed ID: 15194744 [Abstract] [Full Text] [Related]
11. Sensitization of peripheral sensory nerves by mediators from colonic biopsies of diarrhea-predominant irritable bowel syndrome patients: a role for PAR2. Valdez-Morales EE, Overington J, Guerrero-Alba R, Ochoa-Cortes F, Ibeakanma CO, Spreadbury I, Bunnett NW, Beyak M, Vanner SJ. Am J Gastroenterol; 2013 Oct 01; 108(10):1634-43. PubMed ID: 23958521 [Abstract] [Full Text] [Related]
12. Attenuation of the colorectal tonic reflex in female patients with irritable bowel syndrome. Ng C, Danta M, Kellow J, Badcock CA, Hansen R, Malcolm A. Am J Physiol Gastrointest Liver Physiol; 2005 Sep 01; 289(3):G489-94. PubMed ID: 15905412 [Abstract] [Full Text] [Related]
13. Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS. Edogawa S, Edwinson AL, Peters SA, Chikkamenahalli LL, Sundt W, Graves S, Gurunathan SV, Breen-Lyles M, Johnson S, Dyer R, Graham R, Chen J, Kashyap P, Farrugia G, Grover M. Gut; 2020 Jan 01; 69(1):62-73. PubMed ID: 30923071 [Abstract] [Full Text] [Related]
14. Dexamethasone prevents visceral hyperalgesia but not colonic permeability increase induced by luminal protease-activated receptor-2 agonist in rats. Róka R, Ait-Belgnaoui A, Salvador-Cartier C, Garcia-Villar R, Fioramonti J, Eutamène H, Bueno L. Gut; 2007 Aug 01; 56(8):1072-8. PubMed ID: 17309885 [Abstract] [Full Text] [Related]
17. Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice. Du L, Long Y, Kim JJ, Chen B, Zhu Y, Dai N. Dig Dis Sci; 2019 Mar 01; 64(3):729-739. PubMed ID: 30446929 [Abstract] [Full Text] [Related]
18. Increased production of BDNF in colonic epithelial cells induced by fecal supernatants from diarrheic IBS patients. Wang P, Chen FX, Du C, Li CQ, Yu YB, Zuo XL, Li YQ. Sci Rep; 2015 May 22; 5():10121. PubMed ID: 25998025 [Abstract] [Full Text] [Related]
19. Expression of aquaporin 8 in colonic epithelium with diarrhoea-predominant irritable bowel syndrome. Wang JP, Hou XH. Chin Med J (Engl); 2007 Feb 20; 120(4):313-6. PubMed ID: 17374283 [Abstract] [Full Text] [Related]